These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 36997007)
61. Transfer of interleukin-4 and interleukin-10 in patients with severe inflammatory bowel disease of the rectum. Rogy MA; Beinhauer BG; Reinisch W; Huang L; Pokieser P Hum Gene Ther; 2000 Aug; 11(12):1731-41. PubMed ID: 10954907 [TBL] [Abstract][Full Text] [Related]
62. Acupuncture in treating obesity combined with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled clinical trials. Wang Y; Xu GN; Wan RH; Zhou X; Ma LY; Liu B; Zhang YY; Zhou L Complement Ther Clin Pract; 2022 Nov; 49():101658. PubMed ID: 35985055 [TBL] [Abstract][Full Text] [Related]
63. COVID-19 and Outcomes in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. Tripathi K; Godoy Brewer G; Thu Nguyen M; Singh Y; Saleh Ismail M; Sauk JS; Parian AM; Limketkai BN Inflamm Bowel Dis; 2022 Aug; 28(8):1265-1279. PubMed ID: 34718595 [TBL] [Abstract][Full Text] [Related]
64. Tumour necrosis factor-alpha and microalbuminuria in patients with inflammatory bowel disease. Mahmud N; O'Connell MA; Stinson J; Goggins MG; Weir DG; Kelleher D Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):215-9. PubMed ID: 7743302 [TBL] [Abstract][Full Text] [Related]
65. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases. Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413 [TBL] [Abstract][Full Text] [Related]
66. Systematic review with meta-analysis: the efficacy and safety of CT-P13, a biosimilar of anti-tumour necrosis factor-α agent (infliximab), in inflammatory bowel diseases. Komaki Y; Yamada A; Komaki F; Micic D; Ido A; Sakuraba A Aliment Pharmacol Ther; 2017 Apr; 45(8):1043-1057. PubMed ID: 28239873 [TBL] [Abstract][Full Text] [Related]
67. Interleukin-35 and Interleukin-37 anti-inflammatory effect on inflammatory bowel disease: Application of non-coding RNAs in IBD therapy. Reza Lahimchi M; Eslami M; Yousefi B Int Immunopharmacol; 2023 Apr; 117():109932. PubMed ID: 37012889 [TBL] [Abstract][Full Text] [Related]
68. Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel disease. Verstockt B; Van Assche G; Vermeire S; Ferrante M Expert Opin Biol Ther; 2017 Jan; 17(1):31-47. PubMed ID: 27817215 [TBL] [Abstract][Full Text] [Related]
69. Increased Interleukin-10 Expression by the Inhibition of Ca Ohya S; Matsui M; Kajikuri J; Endo K; Kito H J Pharmacol Exp Ther; 2021 Apr; 377(1):75-85. PubMed ID: 33504590 [TBL] [Abstract][Full Text] [Related]
70. Predisposition of Inflammatory Bowel Disease Is Influenced by IL-8, IL-10, and IL-18 Polymorphisms: A Meta-Analysis. Su Y; Zhao H Int Arch Allergy Immunol; 2020; 181(10):799-806. PubMed ID: 32781445 [TBL] [Abstract][Full Text] [Related]
71. Jianpi Qingchang Bushen decoction improves inflammatory response and metabolic bone disorder in inflammatory bowel disease-induced bone loss. Zhang YL; Chen Q; Zheng L; Zhang ZW; Chen YJ; Dai YC; Tang ZP World J Gastroenterol; 2022 Apr; 28(13):1315-1328. PubMed ID: 35645540 [TBL] [Abstract][Full Text] [Related]
72. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111 [TBL] [Abstract][Full Text] [Related]
73. Efficacy and Safety of Acupuncture in Renal Colic Caused by Urinary Calculi in Adults: A Systematic Review and Meta-Analysis. Qu Z; Wang T; Tu J; Yao W; Pei X; Jia L; Cao Y; Liu C Evid Based Complement Alternat Med; 2022; 2022():7140038. PubMed ID: 35832526 [TBL] [Abstract][Full Text] [Related]
74. Massage Acupuncture, Moxibustion, and Other Forms of Complementary and Alternative Medicine in Inflammatory Bowel Disease. Stein DJ Gastroenterol Clin North Am; 2017 Dec; 46(4):875-880. PubMed ID: 29173528 [TBL] [Abstract][Full Text] [Related]
76. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease. Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899 [TBL] [Abstract][Full Text] [Related]
77. Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort. Lee WS; Ng RT; Chan KW; Lau YL World J Gastroenterol; 2016 Dec; 22(48):10653-10662. PubMed ID: 28082818 [TBL] [Abstract][Full Text] [Related]
78. Governor vessel acupuncture for acute ischemic stroke: a systematic review and meta-analysis. Shao TY; Ding MR; Ye ZX; Qian MX; Zhou X; Jin ZQ Ann Palliat Med; 2021 Jul; 10(7):7236-7246. PubMed ID: 34263625 [TBL] [Abstract][Full Text] [Related]
79. Recent advances in biological therapy for inflammatory bowel disease. Kurtovic J; Segal I Trop Gastroenterol; 2004; 25(1):9-14. PubMed ID: 15303463 [TBL] [Abstract][Full Text] [Related]
80. [Interleukin-10 receptor mutations in children with neonatal onset inflammatory bowel disease: genetic diagnosis and pathogenesis]. Lu D; Xu Y; Chen Y; Zeng P; Chen H; Zeng H Zhonghua Er Ke Za Zhi; 2015 May; 53(5):348-54. PubMed ID: 26080664 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]